Zixin Sha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zixin Sha has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Hui Peng
Department of Nephrology, The Third Affiliated Hospital of Sun Yat-Sen University
1 shared publication - Yin Li
Nephrology Division, Department of Medicine The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou China
1 shared publication
Latest Publications
- Open Access
- 25 October 2021
- Published by Wiley in International Journal of Nephrology
- Vol. 2021, 1-6
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases.
- 25 October 2021
- Published by Wiley in International Journal of Nephrology
- Vol. 2021, 1-6
Open AccessMetabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases.